ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2024. The Company also provided a financial outlook for full-year 2025.
ATEC to Present at the 2025 J.P. Morgan Healthcare Conference
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 5:15pm PT on January 15, 2025.
ATEC to Participate in Upcoming Conferences
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:
ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2024, and recent corporate highlights.
ATEC to Report Third Quarter Financial Results on October 30, 2024
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
ATEC to Spotlight Clinically Integrated Informatics at NASS 2024
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will feature its informatics-integrated spine procedures at the North American Spine Society (NASS) 29th Annual Meeting at McCormick Place in Chicago, Illinois, from September 25 to 27, 2024.
ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance
Alphatec Holdings, Inc. (
NASDAQATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2024, and recent corporate highlights.
ATEC to Present at Upcoming Conferences
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:
ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of EOS Insight, a groundbreaking, end-to-end spine surgery platform powered by standardized EOSedge™ scans and AI. With the first customer implementation complete, the EOS Insight-informed surgeries were successfully performed at OrthoIndy Hospital by David G. Schwartz, MD, and Craig McMains, MD.
ATEC to Report Second Quarter Financial Results on July 31, 2024
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2024 financial results on July 31, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2024, and recent corporate highlights.
ATEC to Present at Upcoming Conferences
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:
ATEC to Report First Quarter Financial Results on May 7, 2024
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2023, and business highlights.
ATEC to Present at Upcoming Conferences
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:
ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024.
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of NociscanPartnership aims to include Aclarion’s surgical decision support technology within ATEC’s AlphaInformatiX platform to better inform spine surgery
ATEC to Present at the 2024 J.P. Morgan Healthcare Conference
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 3:45pm PT on January 10, 2024.
ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and recent corporate highlights.
ATEC to Participate in Upcoming Investor Conferences
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor events:
ATEC Equipped to Support Ramping Surgical Volume With Proceeds From Secondary Offering
Alphatec Holdings, Inc. (
NASDAQATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the successful close of a $150 million secondary offering on October 27, 2023, positions the Company to accelerate investment in the revenue-generating assets required to capitalize on industry disruption.
ATEC Announces Closing of Public Stock Offering
Alphatec Holdings, Inc. (“ATEC”) (
NASDAQATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share.
ATEC Announces Pricing of Public Offering of Common Stock
Alphatec Holdings, Inc. (“ATEC”) (
NASDAQATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of an underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share. The offering is expected to close on October 27, 2023, subject to the satisfaction of customary closing conditions. In connection with the offering, ATEC has granted the underwriters a 30-day option to purchase up to an additional 2,145,000 shares of common stock in the offering at the public offering price, less underwriting discounts and commissions.
ATEC Announces Proposed Public Offering of Common Stock
Alphatec Holdings, Inc. (“ATEC”) (
NASDAQATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that it has commenced a proposed underwritten public offering of $150 million of shares of its common stock. In connection with the proposed offering, ATEC intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock sold in the offering. All of the shares in the offering are to be sold by ATEC. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.
ATEC Enhances Board with Renowned Spine Prowess
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Dave Demski, former director and Chief Executive Officer of Globus Medical, has been appointed as an independent director to the Board. The Company also announced that Keith Valentine, former Chief Executive Officer of Orthofix, has been appointed Special Advisor to the Board.
